These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28177099)

  • 1. [The Power of Phosphaturia in the Infrequent Hemodialysis].
    Bolasco P; Murtas S; Caria S; Galfrè A; Esposito MP; Contu R; Deiana ML; Serra A; Cannas K; Caria S; Sitzia I; Scotto P; Spiga P; Concas G
    G Ital Nefrol; 2017; 34(1):. PubMed ID: 28177099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefits of phosphate control in progression of end stage renal disease.
    Bolasco P; Murtas S
    Panminerva Med; 2017 Jun; 59(2):133-138. PubMed ID: 28001025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infrequent and incremental dialysis: differences and definitions].
    Bolasco P; Murtas S
    G Ital Nefrol; 2018 Feb; 35(1):. PubMed ID: 29390238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incremental approach to hemodialysis: twice a week, or once weekly hemodialysis combined with low-protein low-phosphorus diet?].
    Bolasco P; Caria S; Egidi MF; Cupisti A
    G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-weekly hemodialysis combined with low-protein and low-salt dietary treatment as a favorable therapeutic modality for selected patients with end-stage renal failure: a prospective observational study in Japanese patients.
    Nakao T; Kanazawa Y; Takahashi T
    BMC Nephrol; 2018 Jun; 19(1):151. PubMed ID: 29954331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients.
    Caria S; Cupisti A; Sau G; Bolasco P
    BMC Nephrol; 2014 Oct; 15():172. PubMed ID: 25352299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent dialysis: a new paradigm for hemodialysis initiation.
    Rhee CM; Unruh M; Chen J; Kovesdy CP; Zager P; Kalantar-Zadeh K
    Semin Dial; 2013; 26(6):720-7. PubMed ID: 24016197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical procedures to launch a once-weekly-dialysis program integrated into a personalized hypoproteic nutrition (CDDP)].
    Bolasco P; Murtas S
    G Ital Nefrol; 2018 Feb; 35(1):. PubMed ID: 29390244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis.
    Lin YF; Huang JW; Wu MS; Chu TS; Lin SL; Chen YM; Tsai TJ; Wu KD
    Nephrology (Carlton); 2009 Feb; 14(1):59-64. PubMed ID: 19019171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
    Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
    Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6.
    Supasyndh O; Satirapoj B; Seenamngoen S; Yongsiri S; Choovichian P; Vanichakarn S
    J Med Assoc Thai; 2009 May; 92(5):624-31. PubMed ID: 19459522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of switching to nocturnal thrice-weekly hemodialysis on clinical and laboratory parameters: our experience.
    Gubenšek J; Buturović-Ponikvar J; Knap B; Marn Pernat A; Benedik M; Ponikvar R
    Ther Apher Dial; 2013 Aug; 17(4):412-5. PubMed ID: 23931881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine may improve residual renal function in hemodialysis patients: a pilot study.
    Feldman L; Shani M; Sinuani I; Beberashvili I; Weissgarten J
    Hemodial Int; 2012 Oct; 16(4):512-6. PubMed ID: 22541137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Hemodialysis: Is It The Future?
    Libetta C; Nissani P; Dal Canton A
    Semin Dial; 2016 May; 29(3):179-83. PubMed ID: 26567462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Residual Renal Function is Associated With Vascular Calcification in Hemodialysis Patients.
    Chen HC; Chou CY; Jheng JS; Chen IR; Liang CC; Wang SM; Liu JH; Lin SY; Kuo HL; Wang IK; Chang CT; Huang CC
    Ther Apher Dial; 2016 Feb; 20(1):27-30. PubMed ID: 26637989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorus balance with daily dialysis.
    Kooienga L
    Semin Dial; 2007; 20(4):342-5. PubMed ID: 17635826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.